Skip to main content
. Author manuscript; available in PMC: 2012 Apr 23.
Published in final edited form as: J Rehabil Res Dev. 2010;47(1):61–66. doi: 10.1682/jrrd.2008.10.0144

Figure 2.

Figure 2

(A) Average percentage increase in survival via injection treatment with and without NO donors. (B) Flap perfusion of the different nitric oxide treatments and control. SNP=sodium nitroprusside; DETA-NO=diethyltriamine NONOate. N=4 per group. Values are means ± SD. † P<.05 vs. Sham control, * P<.05 vs INJ control.